BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15905174)

  • 21. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression of the mouse corneal crystallin Aldh3a1: activation by Pax6, Oct1, and p300.
    Davis J; Davis D; Norman B; Piatigorsky J
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1814-26. PubMed ID: 18436815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pRb inactivation in senescent cells leads to an E2F-dependent apoptosis requiring p73.
    Alexander K; Yang HS; Hinds PW
    Mol Cancer Res; 2003 Aug; 1(10):716-28. PubMed ID: 12939397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression analysis by gene array of cell cycle modulators in human corneal epithelial cells stimulated with epidermal growth factor (EGF), hepatocyte growth factor (HGF), or keratinocyte growth factor (KGF).
    Lee JS; Liu JJ; Hong JW; Wilson SE
    Curr Eye Res; 2001 Jul; 23(1):69-76. PubMed ID: 11821989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
    Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
    Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity.
    Jang JH; Bruse S; Liu Y; Duffy V; Zhang C; Oyamada N; Randell S; Matsumoto A; Thompson DC; Lin Y; Vasiliou V; Tesfaigzi Y; Nyunoya T
    Free Radic Biol Med; 2014 Mar; 68():80-6. PubMed ID: 24316006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
    Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine- and neurotrophic factor-induced changes in E2F1 localization and phosphorylation of the retinoblastoma susceptibility gene product (pRb) occur by distinct mechanisms in murine cortical cultures.
    Strachan GD; Kopp AS; Koike MA; Morgan KL; Jordan-Sciutto KL
    Exp Neurol; 2005 Jun; 193(2):455-68. PubMed ID: 15869948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
    Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
    Bandyopadhyay D; Medrano EE
    Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique natural antioxidants (NAOs) and derived purified components inhibit cell cycle progression by downregulation of ppRb and E2F in human PC3 prostate cancer cells.
    Bakshi S; Bergman M; Dovrat S; Grossman S
    FEBS Lett; 2004 Aug; 573(1-3):31-7. PubMed ID: 15327971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Cdk2-pRB-E2F1 cell cycle pathway by repeated electroconvulsive shock in the rat frontal cortex.
    Kim Y; Seo MS; Kang UG; Yoon SC; Ahn YM; Kim YS; Juhnn YS
    Biol Psychiatry; 2005 Jan; 57(1):107-9. PubMed ID: 15607308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
    Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
    Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.